LORBRIKA Trademark

Trademark Overview


On Friday, January 19, 2018, a trademark application was filed for LORBRIKA with the United States Patent and Trademark Office. The USPTO has given the LORBRIKA trademark a serial number of 87762144. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, November 27, 2018. This trademark is owned by Pfizer Inc.. The LORBRIKA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
lorbrika

General Information


Serial Number87762144
Word MarkLORBRIKA
Filing DateFriday, January 19, 2018
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, November 27, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, November 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, November 27, 2018ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Tuesday, November 27, 2018ABANDONMENT - AFTER PUBLICATION
Monday, November 26, 2018TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 26, 2018ASSIGNED TO EXAMINER
Wednesday, January 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 23, 2018NEW APPLICATION ENTERED IN TRAM